Introduction
============

Every surgical trauma initiates a certain extent of inflammatory response, which is a part of our immune system.[@b1-vhrm-12-371] However, if excessive, this response can be autodestructive and may lead to complications after surgery.[@b2-vhrm-12-371] The quantification of this inflammatory process can be used as a measurement for surgical trauma,[@b3-vhrm-12-371],[@b4-vhrm-12-371] as well as a prognostic tool.[@b5-vhrm-12-371]--[@b7-vhrm-12-371] Several studies have shown reduced physiological immune response when comparing minimally invasive surgical techniques to the traditional methods.[@b8-vhrm-12-371]--[@b11-vhrm-12-371] Laparoscopic surgery causes less tissue trauma than open surgery and seems to preserve better immune function.[@b12-vhrm-12-371],[@b13-vhrm-12-371] Interleukin-6 (IL-6) is higher after major abdominal surgery and lower after laparoscopic surgery as compared to open surgery.[@b2-vhrm-12-371],[@b14-vhrm-12-371],[@b15-vhrm-12-371] Studies show that patients undergoing laparoscopic aortobifemoral bypass (LABF) surgery have a low postoperative morbidity and mortality.[@b16-vhrm-12-371]--[@b18-vhrm-12-371] In addition, a recently published comparative cohort study showed significantly lower composite end point of all-cause mortality, systemic morbidity, and graft thrombosis after LABF compared with open aortobifemoral bypass (OABF).[@b19-vhrm-12-371]

In this randomized study, we aimed to compare the totally LABF with OABF for the treatment of aortoiliac occlusive disease (AIOD) on the basis of postoperative changes in inflammatory mediators. Only one previous trial has measured the acute-phase response in patients undergoing an LABF, but the trial was not randomized and the hand-assisted minilaparotomy approach was used.[@b20-vhrm-12-371]

Hypothesis
==========

LABF surgery induces a reduced systemic inflammatory response compared with OABF.

Patients and methods
====================

Design
------

This study is a part of an ongoing multicenter, randomized controlled trial (Norwegian Laparoscopic Aortic Surgery Trial \[NLAST\]) at the Department of Vascular Surgery, Oslo University Hospital. Patients with severe symptomatic AIOD, classified according to the Trans-Atlantic Inter-Society Consensus (TASC) II as type D lesions, were randomized to either LABF or OABF procedure.[@b21-vhrm-12-371]

Participants
------------

Participants were included from three vascular surgery departments in the South-East region of Norway, based on the following inclusion and exclusion criteria.

Inclusion criteria: Patient with AIOD, TASC type D lesion,[@b21-vhrm-12-371] and symptoms in the form of intermittent claudication, with walking distance \<200 m and/orchronic critical lower limb ischemia with rest pain or ischemic ulcers (duration of symptoms \>2 weeks).

Exclusion criteria: Eligible for an endovascular procedureCOPD stage IV or more severe, GOLD classification[@b22-vhrm-12-371]Symptomatic coronary heart diseaseChronic heart failure, ejection fraction \<40%Active cancer diseaseHostile abdomen, previous major abdominal surgeryAbdominal aortic aneurysm ≥3.0 cmAcute critical limb ischemia (duration of symptoms ≤2 weeks).

Sample size
-----------

This was a substudy in a larger randomized trial, and an individual power analysis was not conducted on these outcomes.

Randomization and blinding
--------------------------

The patients were enrolled by clinicians and researchers and were randomized to either open or laparoscopic surgery. We used block randomization, with six patients in each block and different sequences for the three participating hospitals. The sequence was random and was not known by the researchers. It was contained in closed, opaque, sequentially numbered envelopes until randomization. Blinding of surgeon and/or participants after randomization was not possible, but laboratory technicians who analyzed the samples were blinded.

Intervention
------------

All procedures were performed by a team with at least one consultant vascular surgeon. The laparoscopic surgeons were passed the learning curve.[@b19-vhrm-12-371],[@b23-vhrm-12-371] The patients underwent aortobifemoral bypass surgery with either a totally laparoscopic approach in accordance with the technique described by Coggia et al[@b24-vhrm-12-371] or a standard open procedure through a median laparotomy. Aortic clamp was placed just below the renal arteries or just above if suprarenal aortic clamping was necessary. Both procedures were performed under general anesthesia.

Ethics
------

The project was completely voluntary and participants gave informed, written consent. The trial was approved by the Regional Committee for Medical and Health Research Ethics, South-East Norway (registration number 2012/1367), and establishment of a biological bank was approved by the Norwegian Data Inspectorate.

Registration
------------

The trial (NLAST) and protocol were registered at [www.clinicaltrials.gov](http://www.clinicaltrials.gov) with the registration number NCT01793662.

Outcomes
--------

Our primary outcome was inflammation due to surgical trauma measured by detecting serum changes in IL-6, IL-8, and C-reactive protein (CRP).

Biochemical analysis
--------------------

We chose to measure IL-6, IL-8, and CRP due to their validity in reflecting the level of acute-phase response in major aortic surgery.[@b20-vhrm-12-371],[@b25-vhrm-12-371] The time points were chosen to capture fluctuation over time. IL-6 and IL-8 usually peak during the first 24 hours postoperatively, but CRP peaks at a later time.[@b10-vhrm-12-371],[@b25-vhrm-12-371],[@b26-vhrm-12-371] Blood samples were taken at the following six different time points: Before surgeryAfter completion of distal anastomosis and flow to one of the lower limbs was reestablishedSix hours after beginning of surgeryTwelve hours after beginning of surgeryTwenty-four hours after beginning of surgeryAt discharge from hospital.

Blood samples were primarily taken from arterial catheter, or if not possible, from central venous catheter or peripheral vein. Samples were centrifuged at 4°C, 1106 *g* within 1 hour from sampling. Two milliliters of serum sample was frozen in plastic Nunc vials, within 2 hours from sampling, at −80°C until further analysis.

Procedure for analysis
----------------------

IL-6 and IL-8 were analyzed at the Hormone Laboratory, Oslo University Hospital, using the MILLIPLEX Map human High Sensitivity T-cell Magnetic Bead Panel (HSTCMAG-28SK, MILLIPLEX^®^ Map Kit; EMD Millipore Corporation, Billerica, MA, USA), while the serum CRP level was analyzed using the immune turbidimetric method performed by an automated machine from ROCHE Module PE Core P800 & E170 Chemistry Analyzer (Hoffmann-La Roche Ltd., Basel, Switzerland).

Statistics
----------

Categorical variables were summarized as frequencies and continuous variables by the median and interquartile range. Comparisons between the two treatment groups were performed using the Mann--Whitney *U*-test for continuous variables and Fisher's exact test for categorical variables. A graphical presentation of the mean serum levels of the inflammatory markers was plotted in SPSS, including calculation of mean and confidence interval for each time point. The three inflammatory markers (CRP, IL-6, and IL-8) were considered as continuous outcomes and measured at four fixed time points for all the subjects. These serial measurements were analyzed univariately, calculating the area under the curve (AUC).[@b27-vhrm-12-371] Differences in AUC between the two groups were evaluated by a parametric test. All markers were analyzed in their logged form due to skewed distribution of data. A multivariate analysis was performed, based on the general estimated equations (GEE) model. In this method, the correlation structure of the data is specified by the investigators at the outset, and the model iterates toward a stable set of estimates to the parameters,[@b28-vhrm-12-371] controlling for confounders or risk factors. Time points two and six were not taken at a fixed point in time (reestablishment of flow through graft and discharge from hospital) and were consequently removed from the AUC and GEE analyses to minimize variability and make the models more robust. Statistical significance was set at a 5% level (*P*\<0.05). We used software from Epi Info (Epi Info™ software; Center for Disease Control and Prevention, Atlanta, GA, USA), IBM SPSS statistics version 22.0 (IBM Corporation, Armonk, NY, USA), MedCalc version 13.1.2 (MedCalc Software, Ostend, Belgium), and Stata 13.0 (StataCorp LP, College Station, TX, USA).

Results
=======

Participant flow and recruitment
--------------------------------

Thirty consecutive patients from the participating hospitals were included from February, 2013 to January, 2015 and randomized to either LABF (n=14) or OABF (n=16) ([Figure 1](#f1-vhrm-12-371){ref-type="fig"}). The patient baseline characteristics in the two groups are given in [Table 1](#t1-vhrm-12-371){ref-type="table"}. One patient was converted from laparoscopic to open surgery and was analyzed in the laparoscopic group, as intention to treat. No patients were excluded after randomization or lost to follow-up at the time of analysis. There were no missing values in the inflammation markers. This substudy trial was completed after the inclusion of 30 patients.

Outcomes and estimation
-----------------------

In [Figures 2](#f2-vhrm-12-371){ref-type="fig"}[](#f3-vhrm-12-371){ref-type="fig"}--[4](#f4-vhrm-12-371){ref-type="fig"}, a graphical presentation of the serum levels of IL-6, IL-8, and CRP is given. All the inflammatory markers increased after surgery compared with baseline. When comparing the individual time point measurements, serum levels of IL-6 was significantly lower after LABF when compared with OABF at 6, 12, and 24 hours postoperatively ([Figure 2](#f2-vhrm-12-371){ref-type="fig"}). The differences in serum levels of IL-8 and CRP did not reach statistical significance ([Figures 3](#f3-vhrm-12-371){ref-type="fig"} and [4](#f4-vhrm-12-371){ref-type="fig"}).

When comparing the summary of the repeated measurements by AUC, mean level of IL-6 was still lower in patients undergoing LABF as compared to OABF ([Table 2](#t2-vhrm-12-371){ref-type="table"}). No statistically significant difference in the mean level of IL-8 or CRP was found in patients undergoing LABF compared with OABF when comparing AUC ([Table 2](#t2-vhrm-12-371){ref-type="table"}). After controlling for the confounding effect of coronary heart disease in a final multivariate analysis ([Table 3](#t3-vhrm-12-371){ref-type="table"}), IL-6 was still significantly lower in the LABF group (*P*=0.010), and the confounding effect was small (8.8 %). There was no statistically significant difference in IL-8 or CRP.

Operation-related parameters are given in [Table 4](#t4-vhrm-12-371){ref-type="table"}. Patients treated with a laparoscopic procedure had a longer aortic clamping time when compared with those treated with open surgery, but significantly less bleeding during surgery. There were only two patients with suprarenal aortic clamping, lasting for only 5 minutes (LABF) versus 3 minutes (OABF).

Clinical outcomes are described in [Table 5](#t5-vhrm-12-371){ref-type="table"}. The patients had significantly shorter hospital stay in the laparoscopic group. There was no statistical difference in postoperative morbidity, and none of the patients died during the study period.

Discussion
==========

There was significantly decreased serum levels of IL-6 after LABF compared with OABF, measured by comparing AUC and after controlling for interdependence and the confounding effect of coronary heart disease (CHD; *P*=0.010). The differences in serum levels of IL-8 and CRP did not reach statistical significance.

The inflammatory response is an interaction of a number of mediators.[@b29-vhrm-12-371] IL-6 is a key agent in the inflammatory process[@b30-vhrm-12-371] and is higher after major abdominal surgery and lower after laparoscopic surgery when compared with open surgery.[@b2-vhrm-12-371],[@b14-vhrm-12-371],[@b15-vhrm-12-371] The manipulation and damage of the peritoneum in laparotomy may be one of the causes.[@b31-vhrm-12-371] IL-8 activity correlates with IL-6 levels after injury or surgical trauma and influences the level of circulating granulocytes and attracts them to the site of injury.[@b29-vhrm-12-371],[@b32-vhrm-12-371] Both IL-6 and IL-8 correlate with the duration of surgery, blood loss, and extent of tissue trauma, among other things.[@b33-vhrm-12-371] IL-6 induces CRP production.[@b34-vhrm-12-371] CRP in turn binds to phosphocholine on damaged cells and microorganisms, which activates the complement pathway and phagocytosis.[@b35-vhrm-12-371] These reactions to surgical trauma are reflected in our patients, who showed an increase in the serum levels of all three inflammatory markers in both groups after surgery ([Figures 2](#f2-vhrm-12-371){ref-type="fig"}[](#f3-vhrm-12-371){ref-type="fig"}--[4](#f4-vhrm-12-371){ref-type="fig"}).

Timing of blood samples is essential for the detection of serial changes in the serum levels of inflammatory markers. In our study population, we did not take any blood samples between 24 hours postoperatively and the discharge of the patient. Watt et al found in their new systematic review from 2015 that serum levels of CRP peak after 24 hours postoperatively. Additional blood samples for CRP in the postoperative period could have been helpful in detecting the serum changes more efficiently.[@b3-vhrm-12-371]

Proinflammatory markers were analyzed at the time of discharge for all the patients. However, the patients were discharged much earlier in the LABF group when compared with the OABF group ([Table 5](#t5-vhrm-12-371){ref-type="table"}), and the variation in sampling time point did not allow a comparison.

The serum concentrations of different cytokines may vary according to location of the sampling site. Concentrations in the portal vein are higher after abdominal surgery.[@b36-vhrm-12-371],[@b37-vhrm-12-371] In this study, the samples were taken primarily from arterial catheter, but in a few cases, they had to be taken from a central venous catheter or peripheral vein. This difference in sampling site could have influenced the serum concentrations of the inflammatory cytokines.

This is a substudy of a randomized trial, which could affect the distribution of known and unknown confounding factors between the two groups, resulting in confounding bias and random effects. There were minor differences in the baseline characteristics, and these factors were deemed as potential confounders. CHD was the most significant confounder, and we investigated the confounding effect of CHD in our final multivariate model. The confounding effect on IL-6 was minor ([Table 3](#t3-vhrm-12-371){ref-type="table"}). We know that the GEE model works best if the number of clusters (patients) is large (n\>50), the number of observations in a cluster is small, and the measurements are taken at the same time for all the subjects.[@b28-vhrm-12-371] Hence, time points four and six had to be removed from the GEE model.

All the inflammatory markers point in the same direction, indicating less inflammatory response after laparoscopic surgery. However, the population of patients in each group was small, and our participants were included from three different hospitals, which may also have influenced the results. The generalizability and external validity of such a small study are questionable, but we have no indication that there was any population bias. The multiplicity of analyses compared to the number of participants could be problematic, and larger trials with patient inclusion based on power analysis may be an aim for further research.

However, randomization and lack of missing values add to the strength of this study. The repeated measurements are significant to capture the serum peak levels, and the statistical analysis comparing AUC is superior to comparing the difference in repeated correlated measurements.[@b27-vhrm-12-371] Also, to the authors' knowledge, this is the first randomized trial on this subject.

An understanding of the inflammatory response to surgery is important to clinicians in the treatment and prevention of complications.[@b38-vhrm-12-371] Different therapeutic regimes have been suggested to balance the reaction between proinflammatory response and immunosuppression and restore immune homeostasis. Nevertheless, reducing the initial trauma has proven to be the most logical strategy.[@b39-vhrm-12-371],[@b40-vhrm-12-371] Our results indicate that LABF is a less invasive technique than OABF.

Conclusion
==========

In this substudy of a randomized controlled trial comparing LABF and OABF surgeries, we found a decreased perioperative inflammatory response, measured by comparing AUC for serum IL-6. An adequately powered randomized trial could be an aim for further research.

We thank all the participating hospitals and staff for all their help, especially the biochemical laboratories of the local hospitals in Kristiansand, Fredrikstad, and Oslo, who provided help in collecting and storing the blood samples, and the Hormone Laboratory, Oslo University Hospital, who analyzed all the samples.
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![Flowchart of patient population with aortoiliac occlusive disease (AIOD) treated with totally laparoscopic aortobifemoral bypass (LABF) or open aortobifemoral bypass (OABF).](vhrm-12-371Fig1){#f1-vhrm-12-371}

![Comparing mean serum level of interleukin-6 (pg/mL) at different time points during and after totally laparoscopic aortobifemoral bypass (LABF) versus open aortobifemoral bypass (OABF).\
**Notes:** Error bars represent the 95% confidence interval (CI). Timepoints: 1, before surgery; 2, after completion of distal anastomosis and flow to one of the lower limbs was reestablished; 3, 6 hours after beginning of surgery; 4, 12 hours after beginning of surgery; 5, 24 hours after beginning of surgery; 6, at discharge from hospital.](vhrm-12-371Fig2){#f2-vhrm-12-371}

![Comparing mean serum level of Interleukin-8 (pg/mL) at different time points during and after totally laparoscopic aortobifemoral bypass (LABF) versus open aortobifemoral bypass (OABF).\
**Notes:** Error bars represent the 95% confidence interval (CI). Timepoints: 1, before surgery; 2, after completion of distal anastomosis and flow to one of the lower limbs was reestablished; 3, 6 hours after beginning of surgery; 4, 12 hours after beginning of surgery; 5, 24 hours after beginning of surgery; 6, at discharge from hospital.](vhrm-12-371Fig3){#f3-vhrm-12-371}

![Comparing mean serum level of C-reactive protein (CRP) (mg/L) at different time points during and after totally laparoscopic aortobifemoral bypass (LABF) versus open aortobifemoral bypass (OABF).\
**Notes:** Error bars represent the 95% confidence interval (CI). Timepoints: 1, before surgery; 2, after completion of distal anastomosis and flow to one of the lower limbs was reestablished; 3, 6 hours after beginning of surgery; 4, 12 hours after beginning of surgery; 5, 24 hours after beginning of surgery; 6, at discharge from hospital.](vhrm-12-371Fig4){#f4-vhrm-12-371}

###### 

Baseline characteristics of patients treated with either totally laparoscopic or open aortobifemoral bypass for severe aortoiliac occlusive disease

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Baseline characteristics                                                                       Laparoscopy\        Open surgery\       *P*-value
                                                                                                 (N=14)              (N=16)              
  ---------------------------------------------------------------------------------------------- ------------------- ------------------- ---------------------------------------------------
  Age (years), mean (SD)                                                                         59 (7.2)            64 (6.8)            0.1043[d](#tfn4-vhrm-12-371){ref-type="table-fn"}

  Female sex, N (%)                                                                              7 (50)              9 (56)              0.5095[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Body mass index (kg/m^2^), mean (SD)                                                           26.3 (4.2)          24.0 (5.1)          0.2056[d](#tfn4-vhrm-12-371){ref-type="table-fn"}

  Current smoker, N (%)                                                                          7 (50)              10 (63)             0.1038[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Hypertension, N (%)                                                                            10 (71)             11 (69)             1.0000[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Renal failure, N (%)                                                                           0 (0)               1 (6)               1.0000[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  COPD, N (%)                                                                                    4 (29)              3 (19)              0.6746[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Hyperlipidemia, N (%)                                                                          5 (36)              2 (13)              0.2040[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Diabetes mellitus, N (%)                                                                       1 (7.1)             0 (0)               0.4667[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Coronary heart disease, N (%)                                                                  2 (14)              5 (31)              0.3992[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Statin, N (%)                                                                                  12 (86)             15 (94)             0.5862[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Acetylsalicylic acid, N (%)                                                                    13 (93)             15 (94)             1.0000[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  ASA classification[a](#tfn1-vhrm-12-371){ref-type="table-fn"}                                                                          

  ASA class 2, N (%)                                                                             0 (0)               1 (6)               1.0000[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  ASA class 3, N (%)                                                                             14 (100)            15 (94)             

  Fontaine classification[b](#tfn2-vhrm-12-371){ref-type="table-fn"}                                                                     

  Fontaine class 3, N (%)                                                                        11 (79)             12 (75)             1.0000[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Fontaine class 4, N (%)                                                                        3 (21)              4 (25)              

  Critical limb ischemia, N (%)                                                                  3 (21)              4 (25)              1.0000[e](#tfn5-vhrm-12-371){ref-type="table-fn"}

  Ankle brachial index[c](#tfn3-vhrm-12-371){ref-type="table-fn"} (preoperative), median (IQR)   0.57 (0.40--0.60)   0.37 (0.27--0.50)   0.0083[d](#tfn4-vhrm-12-371){ref-type="table-fn"}
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

American Society of Anesthesiologists (ASA) classification;

Fontaine classification (classification of symptoms in peripheral atherosclerotic disease);

ABI preoperative) in leg with lowest ABI;

Mann---Whitney *U*-test; and

Fisher's exact test.

**Abbreviations:** ABI, ankle brachial index; IQR, interquartile range; SD, standard deviation.

###### 

Comparison of area under curve (AUC) in laparoscopic aortobifemoral bypass (LABF) versus open aortobifemoral bypass (OABF) for the serum levels of interleukin-6 (IL-6), IL-8, and C-reactive protein (CRP)

  Inflammation marker   Treatment   N    Median   Mean    Logged mean   SD     Difference in logged mean   *t*~df=28~   *P*-value
  --------------------- ----------- ---- -------- ------- ------------- ------ --------------------------- ------------ -----------
  IL-6                  LABF        14   235.9    273.8   50.8          14.2   21.0                        3.300        0.0026
                        OABF        16   965.4    875.9   71.8          19.8                                            
  IL-8                  LABF        14   374.2    463.6   65.7          12.6   10.6                        1.960        0.0600
                        OABF        16   565.5    790.1   76.3          16.4                                            
  CRP                   LABF        14   362.5    464.9   55.8          18.5   2.4                         0.390        0.6993
                        OABF        16   554.4    594.3   58.1          14.8                                            

**Abbreviation:** SD, standard deviation.

###### 

The effect of laparoscopic aortobifemoral bypass (LABF) versus open aortobifemoral bypass (OABF) on serum levels of interleukin-6 (IL-6), IL-8, and C-reactive protein (CRP), controlling for the confounding effect of coronary heart disease, using the general estimated equations (GEE) model

  Inflammation marker   Coefficient   SE       *Z*     *P*-value   Confounding effect
  --------------------- ------------- -------- ------- ----------- --------------------
  IL-6                                                             
   Crude effect         −0.7024       0.2484   −2.83   0.005       
   Adjusted for CHD     −0.6407       0.2488   −2.58   0.010       8.8%
  IL-8                                                             
   Crude effect         −0.2695       0.1973   −1.37   0.172       
   Adjusted for CHD     −0.2360       0.2005   −1.18   0.237       5.3%
  CRP                                                              
   Crude effect         −0.0963       0.3739   −0.26   0.797       
   Adjusted for CHD     −0.0562       0.3808   −0.15   0.883       41.6%

**Note:** The confounding effect is quantified using the formula: (Coefficient~adjusted~ − Coefficient~crude~)/Coefficient~crude~ × 100.

**Abbreviations:** SE, standard error; CHD, coronary heart disease.

###### 

Operation-related parameters for patients treated with either totally laparoscopic or open aortobifemoral bypass for severe aortoiliac occlusive disease

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Parameters                                                                                 Laparoscopy\     Open surgery\        *P*-value
                                                                                             (N=14)           (N=16)               
  ------------------------------------------------------------------------------------------ ---------------- -------------------- ----------------------------------------------------
  Operation time (minutes), median (IQR)                                                     216 (195--235)   202 (169--230)       0.2600[a](#tfn11-vhrm-12-371){ref-type="table-fn"}

  Blood loss during surgery (mL), median (IQR)                                               275 (150--600)   1,000 (575--1,150)   0.0300[a](#tfn11-vhrm-12-371){ref-type="table-fn"}

  Suprarenal clamping, N (%)                                                                 1 (7.1)          1 (6.3)              0.9200[b](#tfn12-vhrm-12-371){ref-type="table-fn"}

  Aortic clamping time (minutes),[c](#tfn13-vhrm-12-371){ref-type="table-fn"} median (IQR)   43 (41--52)      30 (20--38)          0.0002[a](#tfn11-vhrm-12-371){ref-type="table-fn"}
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Statistics:

Mann--Whitney *U*-test;

Fisher's exact *t*-test;

aortic clamping time defined as: time from cross-clamping of the aorta above the proximal anastomosis until the clamp is moved to the proximal end of the graft.

**Abbreviation:** IQR, interquartile range.

###### 

Clinical outcome after laparoscopic aortobifemoral bypass (LABF) versus open aortobifemoral bypass (OABF)

  Clinical outcome                                                                   Laparoscopy      Open surgery      *P*-value
  ---------------------------------------------------------------------------------- ---------------- ----------------- ---------------------------------------------------
  Length of stay in hospital (days), median (IQR)                                    5.0 (4.0--6.0)   9.0 (6.5--11.0)   0.001[a](#tfn16-vhrm-12-371){ref-type="table-fn"}
  Thirty-day mortality, N                                                            0                0                 
  Thirty-day systemic morbidity,[c](#tfn18-vhrm-12-371){ref-type="table-fn"} N (%)   1 (7)            4 (25)            0.210[b](#tfn17-vhrm-12-371){ref-type="table-fn"}

**Notes:** Statistics:

Mann--Whitney *U*-test;

Fisher's exact test; and

systemic morbidity is defined as systemic complications including systemic infection, ileus, sepsis, acute respiratory distress syndrome, multiple organ failure, renal failure, myocardial infarction, and/or cerebral infarction/hemorrhage. Not including local morbidity defined as local wound infection, lymphatic discharge from wound, simple urinary tract infections, pneumonia, or graft occlusion.

**Abbreviation:** IQR, interquartile range.
